<DOC>
	<DOCNO>NCT01904981</DOCNO>
	<brief_summary>Various medical therapy propose prevent abdominal aortic aneurysm expansion . However , randomize clinical trial support use treatment . Several animal study observational report suggest ARBs useful reduce abdominal aortic aneurysm ( AAA ) growth . However , far , ARBs evaluate randomized clinical trial . Therefore , purpose study evaluate effect valsartan , ARB , annual growth rate comparison atenolol , beta-blocker . Our hypothesis valsartan superior atenolol suppression aneurysm growth 12 month . The BASE trial design investigator-initiated , multi-center , randomize control open-label trial . Patients small AAA ( aorta diameter &lt; 5cm ) randomize 1:1 either valsartan atenolol group . Randomization stratify AAA size ( max . diameter &gt; 4 cm ≤4 cm ) . Patients receive either valsartan ( daily dose 80 mg ) atenolol ( daily dose 50 mg ) 12 month . A CT scan measure maximal diameter AAA baseline 12 month . The annual growth AAA compare valsartan atenolol group .</brief_summary>
	<brief_title>Comparison Beta-blocker Versus Angiotensin Receptor Blocker Suppression Aneurysm Expansion Patients With Small Abdominal Aortic Aneurysm Hypertension ( BASE Trial )</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Age ≥20years Abdominal aortic aneurysm maximal diameter le 5cm Hypertension Patient sign informed consent Saccular type aneurysm , inflammatory aneurysm , infect aneurysm Aortic dissection Planned surgery endovascular therapy abdominal aortic aneurysm within 1 year Previous aorta surgery endovascular therapy Contraindications Betablocker ARB ( allergic reaction , asthma , severe bradycardia , angioedema , hyperkalemia ) Allergic reaction contrast dye Known genetic aorta disease autoimmune connective tissue disease : Marfan syndrome , ShprintzenGoldberg syndrome , LoeysDietz syndrome , Takayasu 's arteritis , Behcet 's disease Pregnancy Life expectation &lt; 1 year Renal failure ( serum Cr &gt; 2.0 mg/dL ) Liver disease ( ALT AST &gt; 3 x upper limit ) liver cirrhosis ( Child B C ) Malignancy require surgery chemotherapy within 1 year enrollment Status post transplantation chronic inflammatory disease require immune suppressive drug 4 week</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>